Literature DB >> 667787

Pituitary fibrosarcoma secondary to radiation therapy.

K Ahmad, J V Fayos.   

Abstract

A patient who received postoperative radiation therapy for the treatment of a chromophobe adenoma developed a fibrosarcoma of the pituitary gland region 10 years later. A single course of irradiation was given with a total dose to the pituitary of 4092 rad in 21 fractions and 29 days using Cobalt 60 radiation at a source to skin distance of 80 cm.

Entities:  

Mesh：

Year:  1978        PMID： 667787     DOI： 10.1002/1097-0142(197807)42:1<107::aid-cncr2820420118>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  6 in total

1.  Post radiation sarcoma (malignant fibrous histiocytoma) of the cervical spine following ependymoma (a case report).

Authors:  S Q Nadeem; L G Feun; J H Bruce-Gregorios; B Green
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

2.  Osteosarcoma of the Skull Base after Radiation Therapy in a Patient with McCune-Albright Syndrome: Case Report.

Authors:  Marlan R Hansen; J Craig Moffat
Journal:  Skull Base       Date:  2003-05

3.  Postirradiation meningioma.

Authors:  R Cantini; M Burchianti; M G Fabrini; A M Valleriani; U Simi
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

Review 4.  Sarcomas of the sellar region: a systematic review.

Authors:  Fernando Guerrero-Pérez; Noemi Vidal; Macarena López-Vázquez; Reinaldo Sánchez-Barrera; Juan José Sánchez-Fernández; Alberto Torres-Díaz; Nuria Vilarrasa; Carles Villabona
Journal:  Pituitary       Date:  2021-02       Impact factor: 4.107

Review 5.  Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review.

Authors:  Ryuya Yamanaka; Eisuke Abe; Toshiteru Sato; Azusa Hayano; Yasuo Takashima
Journal:  Cancers (Basel)       Date:  2017-08-08       Impact factor: 6.639

6.  Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib.

Authors:  Daniela Alexandru; Denise K Van Horn; Daniela Annenelie Bota
Journal:  J Neurooncol       Date:  2009-12-31       Impact factor: 4.130
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.